StudyRareStudyRare
Log in to add personal notes on this page.

A family has multiple members with diffuse (signet ring) gastric cancer at young ages. Women in the family also have lobular breast cancer.

AD; CDH1 (E-cadherin, a cell adhesion protein); loss of function, with a second hit in the tumor

E-cadherin is a transmembrane glycoprotein at the basolateral membrane of epithelial cells. Linked to the actin cytoskeleton through catenins, it holds epithelial cells together by calcium-dependent adhesion and suppresses invasion. It also orients the mitotic spindle so that cell division stays in the epithelial plane and both daughter cells keep their contact with the basement membrane.

HDGC is loss of function with a second hit. One CDH1 copy is inherited inactive; the other is lost in the tumor, mainly by promoter hypermethylation in primary tumors and by deletion in lymph node metastases. Loss of E-cadherin is seen in most diffuse gastric cancers and in lobular breast cancers, the two cancers of the syndrome: cells that cannot adhere to each other become invasive and metastasize. Without spindle orientation, dividing cells are also more likely to be displaced into the lamina propria. The full chain of events from E-cadherin loss to cancer is not established.

Two variant-level findings are reported. Variants in the linker regions between the extracellular domains are associated with cleft lip and palate, and the calcium-binding stretch at amino acids 253 to 260 does not tolerate missense change. Founder variants occur in Māori, Newfoundland, and Portuguese families.

  • Diffuse gastric cancer (cumulative risk by age 80: 10-70% in males, 27-56% in females; early estimates were higher)
  • Lobular breast cancer in women (37-42% by age 80)
  • Signet ring cell histology
  • Clinical testing criteria include family clustering of diffuse gastric cancer, an individual with diffuse gastric cancer before age 50, or diffuse gastric cancer plus lobular breast cancer in the same individual or family
  • Confirm with germline CDH1 testing; pathogenic CTNNA1 variants account for a minority of families
  • Endoscopic surveillance has low sensitivity because early signet ring cell foci are submucosal and often invisible, which is why a confirmed germline diagnosis drives the decision for prophylactic gastrectomy
  • Prophylactic gastrectomy (usually age 20-30)
  • Breast cancer surveillance/risk reduction

"Chest + DH1gestive cancer": CDH1 = CaDHerin 1, associated with breast (Chest) and digestive (gastric) cancer. CDH1 encodes E-cadherin, a cell adhesion molecule.

Reference Links